STOCKHOLM, Feb. 15, 2024 /PRNewswire/ — “Storytel continued its transformation journey and delivered yet another strong quarter to conclude 2023”, says Johannes Larcher, CEO, Storytel. Financial Highlights Q4 Fourth quarter 2023 compared to the fourth quarter 2022 Streaming revenue up 16% to 858 (742) MSEK; or 14% at constant exchange rates (CER) Group revenue increased… Continue reading Storytel Interim Report Q4, 2023
Category: Newswire
MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2023
STOCKHOLM, Feb. 15, 2024 /PRNewswire/ — “The clinical efficacy of fostrox in combination with Lenvima continues to improve with median time to progression having increased to over 6 months” October – December Financial summary for the quarter Net turnover amounted to SEK 4.4 (2.3) million. The loss before interest, tax, depreciation and amortization (EBITDA) amounted to… Continue reading MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2023
Storytel Interim Report Q4, 2023
STOCKHOLM, Feb. 15, 2024 /PRNewswire/ — “Storytel continued its transformation journey and delivered yet another strong quarter to conclude 2023”, says Johannes Larcher, CEO, Storytel. Financial Highlights Q4 Fourth quarter 2023 compared to the fourth quarter 2022 Streaming revenue up 16% to 858 (742) MSEK; or 14% at constant exchange rates (CER) Group revenue increased… Continue reading Storytel Interim Report Q4, 2023
Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis
LOS ANGELES, Feb. 15, 2024 /PRNewswire/ — Pharus Diagnostics (“PharusDx”) today announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be used in early screening of individuals at risk for pancreatic ductal adenocarcinoma (PDAC). This license agreement marks a pivotal step with PharusDx to develop and commercialize a… Continue reading Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis
Notice to the Annual General Meeting of Kojamo plc
HELSINKI, Feb. 15, 2024 /PRNewswire/ — Notice to the Annual General Meeting of Kojamo plc Notice is given to the shareholders of Kojamo plc to participate in the Annual General Meeting to be held on Thursday 14 March 2024 at 10.00 a.m. (EET) in Pikku-Finlandia at Karamzininranta 4, Helsinki, Finland. The reception of participants and… Continue reading Notice to the Annual General Meeting of Kojamo plc
Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives
OSLO, Norway, Feb. 15, 2024 /PRNewswire/ — Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announced its results for the fourth quarter and for the full year 2023. Revenues for the year was up 34 per cent to NOK 512 million, mainly by organic… Continue reading Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives
Implantica’s RefluxStop™ now available in Munich
VADUZ, Liechtenstein, Feb. 15, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the first RefluxStop™ procedures completed at Artemed Klinikum München Süd in Munich, Germany. Prof. Thomas Mussack, Chief Physician and Medical Director of the Department of Surgery at Artemed Klinikum München Süd, performed… Continue reading Implantica’s RefluxStop™ now available in Munich
Hybrid Trains Charge Ahead: Market to Reach $48.5 Billion by 2034, Driven by Energy Efficiency and Tech Integration
Rail’s future shines with hybrid trains, powered by digital leaps, operational flexibility, and clean tech. Explore this burgeoning market’s intricate dynamics and uncover stakeholder opportunities in our comprehensive FMI report. NEWARK, Del., Feb. 13, 2024 /PRNewswire/ — The global hybrid train market is anticipated to reach a valuation of US$ 23.4 billion in 2024, driven by… Continue reading Hybrid Trains Charge Ahead: Market to Reach $48.5 Billion by 2034, Driven by Energy Efficiency and Tech Integration
Fleet Management Market worth $55.6 billion by 2028 – Exclusive Report by MarketsandMarkets™
Innovations in telematics, IoT, and AI will propel the Fleet Management Market in the future, bringing with them integration with mobility services, predictive analytics, and a sustainability-focused approach. Regulation adherence, cybersecurity, and personalisation will influence developing business models that prioritise data-driven judgement and effective fleet management. CHICAGO, Feb. 13, 2024 /PRNewswire/ — The Fleet Management… Continue reading Fleet Management Market worth $55.6 billion by 2028 – Exclusive Report by MarketsandMarkets™
Ethara: TICKETS ON SALE NOW FOR FORMULA 1® ETIHAD AIRWAYS ABU DHABI GRAND PRIX 2024 IN DECEMBER
ABU DHABI, UAE, Feb. 13, 2024 /PRNewswire/ — With just weeks to go until the start of the Formula 1® 2024 season, Ethara has announced tickets for this year’s FORMULA 1® ETIHAD AIRWAYS ABU DHABI GRAND PRIX are now on sale, with a range of thrilling experiences and fan favourite vantage points now available for… Continue reading Ethara: TICKETS ON SALE NOW FOR FORMULA 1® ETIHAD AIRWAYS ABU DHABI GRAND PRIX 2024 IN DECEMBER